Search Within

Stuart Lichtman

Formats
  1. Journal Article (154)
  2. Meeting Abstract (46)
  3. Review (8)
  4. Book Section (7)
  5. Editorial (6)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Book Whole (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (228)
  2. Gynecologic Medicine Service (228)
  3. Solid Tumor Oncology Division (228)
  4. Gynecology Disease Management Team (70)
  5. GDMT, Medicine (68)
  6. Hematologic Malignancies, Division of (24)

More Groups

People
  1. William Tew (59)
  2. Carol Aghajanian (15)
  3. Roisin O'Cearbhaill (14)
  4. Jason Konner (13)
  5. Qin Zhou (12)
  6. Alexia Iasonos (11)

More People

Years
  1. 2024 (2)
  2. 2023 (6)
  3. 2022 (12)
  4. 2021 (12)
  5. 2020 (11)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (59)
  2. The Oncology Report (38)
  3. Journal of Geriatric Oncology (26)
  4. Community Oncology (8)
  5. Gynecologic Oncology (7)
  6. The Oncologist (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (65)
  2. Elsevier Inc. (50)
  3. International Medical News Group LLC (38)
  4. Oxford University Press (14)
  5. Wiley Blackwell (8)
  6. C M P Medica LLC * The Oncology Group (5)

More Publishers

Results (228)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline landscape of ovarian cancer across age groups: Spotlight on elderly patients
    Meeting Abstract

    Sia, T. Y.; Moufarrij, S.; Zhou, Q.; Khurram, A.; Kemel, Y.; Iasonos, A.; Long Roche, K.; Stadler, Z. K.; Tew, W. P.; Lichtman, S. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: A phase 2 trial with biomarker analyses
    Journal Article

    Friedman, C. F.; Manning-Geist, B. L.; Zhou, Q.; Soumerai, T.; Holland, A.; Da Cruz Paula, A.; Green, H.; Ozsoy, M. A.; Iasonos, A.; Hollmann, T.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • SIOG COVID-19 Working Group recommendations on COVID-19 therapeutic approaches in older adults with cancer
    Journal Article

    Russo, C.; Mislang, A. R.; Ferraioli, D.; Soto-Perez-de-Celis, E.; Colloca, G.; Williams, G. R.; O'Hanlon, S.; Cooper, L.; O'Donovan, A.; Audisio, R. A.; more...
    Journal of Geriatric Oncology (2023)

    Fulltext@MSK | Save
  • Carboplatin dosing in the treatment of ovarian cancer: An NRG Oncology group study
    Journal Article

    Praiss, A. M.; Miller, A.; Smith, J.; Lichtman, S. M.; Bookman, M.; Aghajanian, C.; Sabbatini, P.; Backes, F.; Cohn, D. E.; Argenta, P.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Feasibility of a geriatric oncology longitudinal end to end (GOLDEN) program in a tertiary cancer center in Singapore
    Journal Article

    Ho, F.; Kow, A.; Lim, W. C.; Chen, M. Z.; Mohd Rais, N. C.; Ling, N. M. W.; Ooi, M.; Ng, J. Y.; Ng, Y. S.; Chun, M.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Chemotherapy dosing in older adults with cancer: One size does NOT fit all
    Editorial

    Williams, G. R.; Outlaw, D.; Harvey, R. D.; Lichtman, S. M.; Zamboni, W. C.; Giri, S.
    Journal of Geriatric Oncology (2023)

    Fulltext@MSK | Save
  • “Geriatricizing” drug development – A Young International Society of Geriatric Oncology letter to the editor
    Correspondence

    Mir, N.; Testa, G. D.; Lichtman, S.
    Journal of Geriatric Oncology (2023)

    Fulltext@MSK | Save
  • Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
    Journal Article

    Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save